These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10530514)

  • 21. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk.
    Lambert JC; Araria-Goumidi L; Myllykangas L; Ellis C; Wang JC; Bullido MJ; Harris JM; Artiga MJ; Hernandez D; Kwon JM; Frigard B; Petersen RC; Cumming AM; Pasquier F; Sastre I; Tienari PJ; Frank A; Sulkava R; Morris JC; St Clair D; Mann DM; Wavrant-DeVrièze F; Ezquerra-Trabalon M; Amouyel P; Hardy J; Haltia M; Valdivieso F; Goate AM; Pérez-Tur J; Lendon CL; Chartier-Harlin MC
    Neurology; 2002 Jul; 59(1):59-66. PubMed ID: 12105308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms of APOE and LRP genes in Brazilian individuals with Alzheimer disease.
    Bahia VS; Kok F; Marie SN; Shinjo SO; Caramelli P; Nitrini R
    Alzheimer Dis Assoc Disord; 2008; 22(1):61-5. PubMed ID: 18317248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease.
    Rebeck GW; Cheung BS; Growdon WB; Deng A; Akuthota P; Locascio J; Greenberg SM; Hyman BT
    Neurosci Lett; 1999 Sep; 272(3):155-8. PubMed ID: 10505604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
    Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene.
    Artiga MJ; Bullido MJ; Frank A; Sastre I; Recuero M; García MA; Lendon CL; Han SW; Morris JC; Vázquez J; Goate A; Valdivieso F
    Hum Mol Genet; 1998 Nov; 7(12):1887-92. PubMed ID: 9811931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Confirmation of the association between bleomycin hydrolase genotype and Alzheimer's disease.
    Papassotiropoulos A; Bagli M; Jessen F; Frahnert C; Rao ML; Maier W; Heun R
    Mol Psychiatry; 2000 Mar; 5(2):213-5. PubMed ID: 10822352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The -491 A/T polymorphism in the regulatory region of the apolipoprotein E gene and early-onset Alzheimer's disease.
    Roks G; Cruts M; Bullido MJ; Backhovens H; Artiga MJ; Hofman A; Valdivieso F; Van Broeckhoven C; Van Duijn CM
    Neurosci Lett; 1998 Dec; 258(2):65-8. PubMed ID: 9875528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
    Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW
    Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer's disease.
    Bratosiewicz-Wasik J; Liberski PP; Peplonska B; Styczynska M; Smolen-Dzirba J; Cycon M; Wasik TJ
    Neurosci Lett; 2018 Sep; 684():86-90. PubMed ID: 29990559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The --491 TT apolipoprotein E promoter polymorphism is associated with reduced risk for sporadic Alzheimer's disease.
    Alvarez-Arcaya A; Combarros O; Llorca J; Sánchez-Guerra M; Berciano J; Fernández-Luna JL
    Neurosci Lett; 2001 May; 304(3):204-8. PubMed ID: 11343837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E -491 promoter polymorphism is an independent risk factor for Alzheimer's disease in the Chinese population.
    Yang JD; Feng GY; Zhang J; Cheung J; St Clair D; He L; Ichimura K
    Neurosci Lett; 2003 Oct; 350(1):25-8. PubMed ID: 12962909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription.
    Laws SM; Hone E; Gandy S; Martins RN
    J Neurochem; 2003 Mar; 84(6):1215-36. PubMed ID: 12614323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of IL10 promoter polymorphism in Italian Alzheimer's disease.
    Bagnoli S; Cellini E; Tedde A; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
    Neurosci Lett; 2007 May; 418(3):262-5. PubMed ID: 17420099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer's disease.
    Maloney B; Ge YW; Alley GM; Lahiri DK
    J Neurochem; 2007 Nov; 103(3):1237-57. PubMed ID: 17854398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease.
    Licastro F; Pedrini S; Govoni M; Pession A; Ferri C; Annoni G; Casadei V; Veglia F; Bertolini S; Grimaldi LM
    Neurosci Lett; 1999 Aug; 270(3):129-32. PubMed ID: 10462111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic analysis of vascular factors in Alzheimer's disease.
    Wakutani Y; Kowa H; Kusumi M; Yamagata K; Wada-Isoe K; Adachi Y; Takeshima T; Urakami K; Nakashima K
    Ann N Y Acad Sci; 2002 Nov; 977():232-8. PubMed ID: 12480755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
    Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
    Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of apolipoprotein E gene polymorphisms in Japanese patients with Alzheimer's disease and in Japanese centenarians.
    Yamagata Z; Asada T; Kinoshita A; Zhang Y; Asaka A
    Hum Hered; 1997; 47(1):22-6. PubMed ID: 9017975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are the associations between Alzheimer's disease and polymorphisms in the apolipoprotein E and the apolipoprotein CII genes due to linkage disequilibrium?
    Tsuda T; Lopez R; Rogaeva EA; Freedman M; Rogaev E; Drachman D; Pollen D; Haines J; Liang Y; McLachlan DR
    Ann Neurol; 1994 Jul; 36(1):97-100. PubMed ID: 8024269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The -491A/T polymorphism of the Apolipoprotein E gene is associated with the ApoEepsilon4 allele and Alzheimer's disease.
    Ahmed AR; MacGowan SH; Culpan D; Jones RW; Wilcock GK
    Neurosci Lett; 1999 Mar; 263(2-3):217-9. PubMed ID: 10213175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.